Jeff Yass’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-64,759
Closed -$663K 13342
2026
Q1
$663K Buy
64,759
+40,399
+166% +$340K ﹤0.01% 8930
2025
Q4
$153K Buy
+24,360
New +$134K ﹤0.01% 11148
2025
Q2
Sell
-27,681
Closed -$40.4K 12602
2025
Q1
$40.4K Sell
27,681
-22,107
-44% -$44K ﹤0.01% 11925
2024
Q4
$92.1K Buy
49,788
+20,002
+67% +$45K ﹤0.01% 11397
2024
Q3
$70.6K Sell
29,786
-34,226
-53% -$87.5K ﹤0.01% 11235
2024
Q2
$176K Sell
64,012
-23,791
-27% -$67.9K ﹤0.01% 10521
2024
Q1
$367K Buy
+87,803
New +$318K ﹤0.01% 9239
2023
Q1
Sell
-10,247
Closed -$12.7K 12520
2022
Q4
$12.7K Buy
+10,247
New +$26.7K ﹤0.01% 11886
2022
Q1
Sell
-12,032
Closed -$66K 12927
2021
Q4
$66K Buy
+12,032
New +$50.3K ﹤0.01% 12415
2020
Q1
Sell
-14,688
Closed -$48K 10188
2019
Q4
$48K Buy
+14,688
New +$59.1K ﹤0.01% 9353
2019
Q2
Sell
-1,286
Closed -$5K 10178
2019
Q1
$5K Buy
+1,286
New +$4.89K ﹤0.01% 8675
2018
Q3
Sell
-2,280
Closed -$36K 9163
2018
Q2
$36K Buy
+2,280
New +$37.1K ﹤0.01% 9336
2017
Q2
Sell
-183
Closed -$11K 9152
2017
Q1
$11K Buy
+183
New +$12.4K ﹤0.01% 8780

Other funds holding ARMP

Jeff Yass's ARMP Position: Q2 2026 in Review

Jeff Yass sold out of Armata Pharmaceuticals (ARMP) in Q2 2026, closing a stake of 64,759 shares — an estimated $663K sold.

Jeff Yass first reported a position in ARMP in Q1 2017 and held it in 13 quarters. The position peaked at $663K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Jeff Yass reported no remaining Armata Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 64,759 Armata Pharmaceuticals shares in Q2 2026, an estimated $663K.
  • Jeff Yass first reported a position in Armata Pharmaceuticals in Q1 2017 and held it in 13 quarters.
  • Jeff Yass's Armata Pharmaceuticals position peaked at $663K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.